Hyloris Announces Approval Of Condylox First Generic

US FDA Authorizes Podofilox Product With 180-Day CGT Exclusivity

 
• By Chloe Kent
FDA building.
Approval marks Hyloris' second in the US this year after Maxigesic IV • Source: Shutterstock

More from Products

More from Generics Bulletin